AbbVie Long-Term Investments 2010-2024 | ABBV

AbbVie long-term investments for the quarter ending September 30, 2024 were $0.267B, a 2.91% decline year-over-year.

  • AbbVie long-term investments for 2023 were $0.304B, a 26.14% increase from 2022.
  • AbbVie long-term investments for 2022 were $0.241B, a 13% decline from 2021.
  • AbbVie long-term investments for 2021 were $0.277B, a 5.46% decline from 2020.

AbbVie Long-Term Investments 2010-2024 | ABBV

  • AbbVie long-term investments for 2023 were $0.304B, a 26.14% increase from 2022.
  • AbbVie long-term investments for 2022 were $0.241B, a 13% decline from 2021.
  • AbbVie long-term investments for 2021 were $0.277B, a 5.46% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$710.1B
Novo Nordisk (NVO)$471.5B
Johnson & Johnson (JNJ)$373.6B
Merck (MRK)$250.9B
Novartis AG (NVS)$213.1B
AstraZeneca (AZN)$203.5B
Pfizer (PFE)$145.4B
Sanofi (SNY)$122.5B
Innoviva (INVA)$1.2B